Get all the updates for this publication
Articles
Molecular and immunological biomarkers to predict IVIg responsePublished in Elsevier Ltd
2015
PMID: 25680699
Volume: 21
Issue: 3
Pages: 145 - 147
Some patients with autoimmune and inflammatory diseases treated with intravenous immunoglobulin G (IVIg) as a first line therapy are refractory. Identification of predictive biomarker(s) to segregate responders and non-responders to IVIg therapy remains critical. A number of biomarkers, particularly in Kawasaki disease, have shown potential for predicting response to IVIg. © 2015 Elsevier Ltd.
Postprint Version
Content may be subject to copyright,Check License© This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc... ...© This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/
About the journal
| Journal | Data powered by TypesetTrends in Molecular Medicine |
|---|---|
| Publisher | Data powered by TypesetElsevier Ltd |
| ISSN | 14714914 |
| Open Access | No |
Authors (1)
Jagadeesh Bayry- Restoration of established systemic inflammation and autoimmunity by Foxp3+ regulatory T cells
- Recent advances and prospects of hyaluronan as a multifunctional therapeutic system
- Species-Specific Immunological Reactivities Depend on the Cell-Wall Organization of the Two Aspergillus, Aspergillus fumigatus and A. flavus
- Editorial: The Role of the Fungal Cell Wall in Host-Fungal Interactions
